Medicalgorithmics S.A.

DB:B8E Stock Report

Market Cap: €60.4m

Medicalgorithmics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Kris Siemionow

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.7yrs
CEO ownershipn/a
Management average tenure1.7yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

CEO

Kris Siemionow

1.7yrs
Tenure

Dr. Krzysztof Siemionow, M.D., Ph D., also known as Kris, is President of the Management Board & CEO of Medicalgorithmics S.A. from 2025. Dr. Siemionow serves as Member of Supervisory Board at MultiQure S....

Leadership Team

NamePositionTenureCompensationOwnership
Krzysztof Siemionow
President of the Management Board & CEO1.7yrsno datano data
Michal Zapora
CFO & Member of the Management Board1.7yrsno datano data
Jaroslaw Jerzakowski
Chief Operating Officer2.7yrszł482.00kno data
Przemyslaw Tadla
Chief Technology Officer2.7yrszł385.00kno data
Linda Johnson
Chief Scientific Officerno datano datano data
Catalina Guzman
Marketing Manager1.7yrsno datano data
1.7yrs
Average Tenure

Experienced Management: B8E's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Michal Wnorowski
Independent Vice Chairman of the Supervisory Board5.7yrszł161.00kno data
Marzena Piszczek
Member of the Supervisory Board2.3yrszł155.00kno data
Pawel Lewicki
Supervisory Board Member3.8yrsno datano data
Marcin Golebicki
Member of Supervisory Boardno datazł16.00kno data
Michal Zoltowski
Chairman of the Supervisory Board1.7yrszł83.00kno data
Maksymilian Fraszka
Member of the Supervisory Board1.7yrszł52.00kno data
2.3yrs
Average Tenure

Experienced Board: B8E's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 23:01
End of Day Share Price 2026/09/11 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medicalgorithmics S.A. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adrian KowollikEast Value Research GmbH
Lukasz KosiarskiIpopema Securities S.A.
Gabriela BurdachWood & Company